Literature DB >> 33669580

Is Probiotic Supplementation Useful for the Management of Body Weight and Other Anthropometric Measures in Adults Affected by Overweight and Obesity with Metabolic Related Diseases? A Systematic Review and Meta-Analysis.

Simone Perna1, Zahra Ilyas1, Attilio Giacosa2, Clara Gasparri3, Gabriella Peroni3, Milena Anna Faliva3, Chiara Rigon3, Maurizio Naso3, Antonella Riva4, Giovanna Petrangolini4, Ali A Redha5, Mariangela Rondanelli6,7.   

Abstract

The aim of this systematic review and meta-analysis is to assess the effectiveness of probiotics in inducing body weight loss in patients with overweight or obesity with related metabolic diseases. The research was carried out on PubMed and Scopus, focusing on studies reporting the effect on anthropometric measures (weight, body mass Index (BMI), waist circumference (WC), and hip circumference (HC) after administration of various probiotic strains compared to placebo. Twenty randomized controlled trials, that included 1411 patients, were considered. The meta-analyzed mean differences (MD) for random effects showed no significant decrease in body weight after probiotic supplementation (-0.26 kg [-075, 0.23], p = 0.30), while a significant BMI decrease was found (-0.73 kg/m2 [-1.31, -0.16], p = 0.01). For WC and HC, the meta-analyzed MD for random effects showed a significant decrease (WC: -0.71 cm [-1.24; -0.19], p = 0.008 and HC: -0.73 cm [-1.16; -0.30], p = 0.0008). The risk of bias was also evaluated considering a high risk and a low risk according to PRISMA criteria. In conclusion, the results of this meta-analysis highlight a positive trend of probiotics supplementation on the amelioration of anthropometric measures of overweight and obese patients with related metabolic diseases. However, further research is needed before recommending the use of probiotics as a therapeutic strategy for these patients. The focus of the future research should be to evaluate the efficacy of different probiotic strains, the quantities to be administered, and the duration of the intervention.

Entities:  

Keywords:  body weight; obesity; probiotics; weight loss

Mesh:

Year:  2021        PMID: 33669580      PMCID: PMC7922558          DOI: 10.3390/nu13020666

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  58 in total

1.  Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans.

Authors:  Reiner Jumpertz; Duc Son Le; Peter J Turnbaugh; Cathy Trinidad; Clifton Bogardus; Jeffrey I Gordon; Jonathan Krakoff
Journal:  Am J Clin Nutr       Date:  2011-05-04       Impact factor: 7.045

2.  Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability.

Authors:  Andreas Hiergeist; Udo Reischl; Andrè Gessner
Journal:  Int J Med Microbiol       Date:  2016-03-21       Impact factor: 3.473

Review 3.  Microbiota and cardiovascular disease risk: A scoping review.

Authors:  Federico Scarmozzino; Andrea Poli; Francesco Visioli
Journal:  Pharmacol Res       Date:  2020-05-31       Impact factor: 7.658

4.  Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women.

Authors:  Marina Sanchez; Christian Darimont; Vicky Drapeau; Shahram Emady-Azar; Melissa Lepage; Enea Rezzonico; Catherine Ngom-Bru; Bernard Berger; Lionel Philippe; Corinne Ammon-Zuffrey; Patricia Leone; Genevieve Chevrier; Emmanuelle St-Amand; André Marette; Jean Doré; Angelo Tremblay
Journal:  Br J Nutr       Date:  2013-12-03       Impact factor: 3.718

5.  Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

Authors:  Luying Peng; Zhong-Rong Li; Robert S Green; Ian R Holzman; Jing Lin
Journal:  J Nutr       Date:  2009-07-22       Impact factor: 4.798

6.  Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.

Authors:  A Alisi; G Bedogni; G Baviera; V Giorgio; E Porro; C Paris; P Giammaria; L Reali; F Anania; V Nobili
Journal:  Aliment Pharmacol Ther       Date:  2014-04-16       Impact factor: 8.171

Review 7.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

8.  Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes.

Authors:  Hossein Shakeri; Haleh Hadaegh; Fatemeh Abedi; Maryam Tajabadi-Ebrahimi; Navid Mazroii; Yaser Ghandi; Zatollah Asemi
Journal:  Lipids       Date:  2014-04-06       Impact factor: 1.880

9.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.

Authors:  M Million; M Maraninchi; M Henry; F Armougom; H Richet; P Carrieri; R Valero; D Raccah; B Vialettes; D Raoult
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

10.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

View more
  6 in total

1.  New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis.

Authors:  Alexander Kalinkovich; Maria Becker; Gregory Livshits
Journal:  Drugs Aging       Date:  2022-07-04       Impact factor: 4.271

2.  Effects of Multispecies Synbiotic Supplementation on Anthropometric Measurements, Glucose and Lipid Parameters in Children With Exogenous Obesity: A Randomized, Double Blind, Placebo-Controlled Clinical Trial (Probesity-2 Trial).

Authors:  Gonca Kilic Yildirim; Meltem Dinleyici; Yvan Vandenplas; Ener Cagri Dinleyici
Journal:  Front Nutr       Date:  2022-07-01

Review 3.  Probiotics as a Treatment for "Metabolic Depression"? A Rationale for Future Studies.

Authors:  Oliwia Gawlik-Kotelnicka; Dominik Strzelecki
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-20

4.  Randomized Clinical Trial: Probiotics Alleviated Oral-Gut Microbiota Dysbiosis and Thyroid Hormone Withdrawal-Related Complications in Thyroid Cancer Patients Before Radioiodine Therapy Following Thyroidectomy.

Authors:  Baiqiang Lin; Fuya Zhao; Yang Liu; Xin Wu; Jing Feng; Xiangren Jin; Wei Yan; Xiao Guo; Shang Shi; Zhiyong Li; Lujia Liu; Hongye Chen; Haoran Wang; Shuang Wang; Yu Lu; Yunwei Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

Review 5.  Metabolic control by the microbiome.

Authors:  Timothy O Cox; Patrick Lundgren; Kirti Nath; Christoph A Thaiss
Journal:  Genome Med       Date:  2022-07-29       Impact factor: 15.266

6.  A rational definition for functional foods: A perspective.

Authors:  Norman J Temple
Journal:  Front Nutr       Date:  2022-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.